ClinicalTrials.Veeva

Menu
H

Helix Biomedics LLC | Boynton Beach, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Elagolix
Vilaprisan
Elinzanetant
BAY3427080
Amlitelimab
Estradiol
SAR440340
AVP-786
SEL-212
Dupilumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 23 total trials

A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD (AERIFY-4)

This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab (SAR440340)

Researchers are looking for a better way to treat women who have sleep disturbances associated with menopause.Menopause is part of a natural aging pr...

Active, not recruiting
Sleep Disturbances Associated With Menopause
Other: Placebo
Drug: Elinzanetant

This is a parallel, Phase 2, global, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, four-arms study for treatment.The purpo...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Amlitelimab

This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatment period...

Enrolling
Asthma
Drug: Placebo
Drug: Amlitelimab

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

Endometriosis is a painful disorder of the uterus affecting 6-10% of women of childbearing age. Endometriosis affects daily activities, social relati...

Enrolling
Endometriosis
Drug: Elagolix
Drug: Placebo

Primary Objective:Primary population (former smokers cohort):* Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of ac...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab SAR440340

Trial sponsors

Bayer logo
AbbVie logo
Sanofi logo
Astellas logo
Avalo Therapeutics logo
Avillion logo
Boehringer Ingelheim logo
Otsuka logo
Sobi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems